Factsheet: From Vaccines to Vaccinations
Who We Are
Sabin Vaccine Institute unlocks the full benefits of vaccines to protect people everywhere. We turn innovation into impact: developing vaccines, responding to vaccine-preventable outbreaks, and driving data and policy that expand immunization and save lives worldwide.
What We Do
Advance Impactful Vaccines
License promising vaccines for high-risk diseases that lack strong commercial markets and move them from early research through clinical development.
Respond to Outbreaks
Work with governments in their response efforts by providing investigational vaccines and expertise to conduct clinical trials during outbreaks, and provide technical expertise to deliver vaccines.
Inform Policy and Drive Vaccine Acceptance
Generate evidence and work with government and local partners to overcome barriers, increase demand, and strengthen immunization delivery systems.
Drive Evidence for Surveillance and Vaccine Introduction
Conduct studies with governments and local partners for effective and efficient vaccine prioritization and introductions.
Why We Do it
Fill Market Gap
Companies may not have commercial incentive to invest in vaccines for diseases that primarily impact low-income countries.
Address Surging Disease Threats
Climate change, urbanization, and environmental disruption are accelerating the spread of infectious diseases and increasing the risk of outbreaks.
Close Immunization Gaps
Over 14 million children have not received a single vaccine — leaving millions vulnerable to preventable disease.
Strengthen Vaccine Confidence
Misinformation and declining trust are driving uneven uptake and the resurgence of diseases like measles and polio.
Optimize Resources
Resilient health systems are essential to provide quality care and respond to outbreaks. Many low- and middle-income countries face human and financial constraints requiring smarter, more efficient health and immunization strategies.
Progress in Research & Development
2
Vaccines for prevention of disease caused by Marburg or Sudan virus
2,800
Participants enrolled in clinical trials
3
Clinical trials for Marburg and Sudan Virus Disease Outbreak
6
Phase 2 clinical trials in 5 countries: Kenya, Uganda, Rwanda, Ethiopia, and U.S.
Growth in Global Immunization
5,500+
Immunization professionals from 160 countries in Boost’s peer-to-peer community learning from one another
500+
Researchers in Vaccine Acceptance Research Network (VARN) addressing behavioral science to increase vaccine coverage
170+
Countries covered by Global HPV Consortium partners to eliminate cervical cancer around the globe
4,678
Patients screened over 10 years in Bangladesh and Nepal to investigate the impact of typhoid and paratyphoid in the region
Why Work With Sabin
- Vaccines to vaccination approach: We span the vaccine continuum, from development to delivery.
- Community-rooted: We strengthen local leadership and immunization systems, building sustainable capacity.
- Evidence-based: Whether it’s vaccine science or policy, Sabin initiatives are grounded in rigorous data and research.
- Trusted convener for impactful knowledge-sharing: We convene researchers, immunization professionals, and policymakers to share research and best practices to accelerate progress.
“Sabin bridges the gap between scientific innovation and community delivery, ensuring that the life-saving potential of vaccines reaches the people who need them most. ”
Amy Finan
Chief Executive Officer
Recommended for You
Factsheet: From Vaccines to Vaccinations
We make vaccines more accessible, enable innovation and expand immunization across the globe.